Hereditary breast/ovarian cancer - Pitfalls in genetic counseling

E. Dagan, R. Gershoni-Baruch

Research output: Contribution to journalArticlepeer-review


Genetic counseling and risk assessment, given to women with a family history of breast/ovarian cancer, are regularly based on pedigree analysis. In the Ashkenazi Jewish population, hereditary breast/ovarian cancer is mainly attributed to three founder mutations, namely, 185delAG, 5382insC, and 6174delT, in BRCA1/2 genes. The overall frequency of these mutations, in the Jewish Ashkenazi population, is as high as 2.5%. Based on clinical and family history data, the results of BRCA molecular testing, in Ashkenazi individuals at risk, are appropriately anticipated in most cases. Here we report on five families, in which the segregation of BRCA1/2 mutations, in affected and unaffected family members, was unexpected, emphasizing the need to test, for founder mutations, every Ashkenazi individual at risk, irrespective of the genotype of affected family members. Ultimately, risk assessments and recommendations, in Ashkenazi women, should be invariably based on the results of genetic testing.

Original languageEnglish
Pages (from-to)310-313
Number of pages4
JournalClinical Genetics
Issue number4
StatePublished - 2001


  • Genetic counseling
  • Hereditary breast cancer
  • Ovarian cancer

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics


Dive into the research topics of 'Hereditary breast/ovarian cancer - Pitfalls in genetic counseling'. Together they form a unique fingerprint.

Cite this